AZENTA INC (AZTA) Fundamental Analysis & Valuation
NASDAQ:AZTA • US1143401024
Current stock price
22.21 USD
-0.45 (-1.99%)
At close:
22.21 USD
0 (0%)
After Hours:
This AZTA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. AZTA Profitability Analysis
1.1 Basic Checks
- AZTA had positive earnings in the past year.
- AZTA had a positive operating cash flow in the past year.
- In multiple years AZTA reported negative net income over the last 5 years.
- AZTA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- With a Return On Assets value of -2.79%, AZTA perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
- The Return On Equity of AZTA (-3.37%) is better than 61.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.79% | ||
| ROE | -3.37% | ||
| ROIC | N/A |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- AZTA has a Gross Margin of 44.59%. This is comparable to the rest of the industry: AZTA outperforms 42.11% of its industry peers.
- In the last couple of years the Gross Margin of AZTA has remained more or less at the same level.
- The Profit Margin and Operating Margin are not available for AZTA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.59% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
2. AZTA Health Analysis
2.1 Basic Checks
- AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, AZTA has more shares outstanding
- AZTA has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, AZTA has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 3.21 indicates that AZTA is not in any danger for bankruptcy at the moment.
- AZTA has a better Altman-Z score (3.21) than 70.18% of its industry peers.
- AZTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.21 |
ROIC/WACCN/A
WACC10.9%
2.3 Liquidity
- AZTA has a Current Ratio of 2.92. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
- With a Current ratio value of 2.92, AZTA perfoms like the industry average, outperforming 54.39% of the companies in the same industry.
- AZTA has a Quick Ratio of 2.61. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 2.61, AZTA is in line with its industry, outperforming 57.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.92 | ||
| Quick Ratio | 2.61 |
3. AZTA Growth Analysis
3.1 Past
- AZTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.89%, which is quite good.
- Measured over the past years, AZTA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.04% on average per year.
- The Revenue has decreased by -8.40% in the past year.
- The Revenue has been growing by 8.86% on average over the past years. This is quite good.
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%
3.2 Future
- The Earnings Per Share is expected to grow by 27.49% on average over the next years. This is a very strong growth
- AZTA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.37% yearly.
EPS Next Y50.47%
EPS Next 2Y43.51%
EPS Next 3Y35.52%
EPS Next 5Y27.49%
Revenue Next Year5.15%
Revenue Next 2Y5.46%
Revenue Next 3Y5.78%
Revenue Next 5Y5.37%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. AZTA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 41.13, which means the current valuation is very expensive for AZTA.
- Compared to the rest of the industry, the Price/Earnings ratio of AZTA indicates a somewhat cheap valuation: AZTA is cheaper than 61.40% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 26.78, AZTA is valued quite expensively.
- A Price/Forward Earnings ratio of 20.35 indicates a rather expensive valuation of AZTA.
- Based on the Price/Forward Earnings ratio, AZTA is valued a bit cheaper than the industry average as 78.95% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 23.54. AZTA is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.13 | ||
| Fwd PE | 20.35 |
4.2 Price Multiples
- AZTA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AZTA is cheaper than 84.21% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of AZTA indicates a somewhat cheap valuation: AZTA is cheaper than 63.16% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.07 | ||
| EV/EBITDA | 13.54 |
4.3 Compensation for Growth
- AZTA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- AZTA's earnings are expected to grow with 35.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.81
PEG (5Y)N/A
EPS Next 2Y43.51%
EPS Next 3Y35.52%
5. AZTA Dividend Analysis
5.1 Amount
- No dividends for AZTA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AZTA Fundamentals: All Metrics, Ratios and Statistics
22.21
-0.45 (-1.99%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)05-05 2026-05-05/amc
Inst Owners116.07%
Inst Owner Change0.01%
Ins Owners0.69%
Ins Owner Change12.39%
Market Cap1.02B
Revenue(TTM)594.95M
Net Income(TTM)-57.85M
Analysts77.14
Price Target37.74 (69.92%)
Short Float %10.54%
Short Ratio5.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.65%
Min EPS beat(2)-35.95%
Max EPS beat(2)8.65%
EPS beat(4)2
Avg EPS beat(4)-5.26%
Min EPS beat(4)-35.95%
Max EPS beat(4)36.22%
EPS beat(8)6
Avg EPS beat(8)46.66%
EPS beat(12)9
Avg EPS beat(12)140.12%
EPS beat(16)13
Avg EPS beat(16)118.13%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.7%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)-0.05%
Revenue beat(8)1
Avg Revenue beat(8)-1.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)-1.08%
PT rev (1m)-1.89%
PT rev (3m)-4.78%
EPS NQ rev (1m)-0.49%
EPS NQ rev (3m)-24.05%
EPS NY rev (1m)-0.71%
EPS NY rev (3m)-0.16%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)0.47%
Revenue NY rev (3m)0.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.13 | ||
| Fwd PE | 20.35 | ||
| P/S | 1.72 | ||
| P/FCF | 33.07 | ||
| P/OCF | 16.39 | ||
| P/B | 0.6 | ||
| P/tB | 1.12 | ||
| EV/EBITDA | 13.54 |
EPS(TTM)0.54
EY2.43%
EPS(NY)1.09
Fwd EY4.91%
FCF(TTM)0.67
FCFY3.02%
OCF(TTM)1.35
OCFY6.1%
SpS12.92
BVpS37.23
TBVpS19.88
PEG (NY)0.81
PEG (5Y)N/A
Graham Number21.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.79% | ||
| ROE | -3.37% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.59% | ||
| FCFM | 5.2% |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.29
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 55.45% | ||
| Cap/Sales | 5.29% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 156.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.92 | ||
| Quick Ratio | 2.61 | ||
| Altman-Z | 3.21 |
F-Score5
WACC10.9%
ROIC/WACCN/A
Cap/Depr(3y)47.53%
Cap/Depr(5y)73.52%
Cap/Sales(3y)6.46%
Cap/Sales(5y)8.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
EPS Next Y50.47%
EPS Next 2Y43.51%
EPS Next 3Y35.52%
EPS Next 5Y27.49%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%
Revenue Next Year5.15%
Revenue Next 2Y5.46%
Revenue Next 3Y5.78%
Revenue Next 5Y5.37%
EBIT growth 1Y71.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year493.88%
EBIT Next 3Y107.95%
EBIT Next 5YN/A
FCF growth 1Y-4.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.01%
OCF growth 3YN/A
OCF growth 5Y13.75%
AZENTA INC / AZTA Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for AZENTA INC?
ChartMill assigns a fundamental rating of 5 / 10 to AZTA.
What is the valuation status for AZTA stock?
ChartMill assigns a valuation rating of 5 / 10 to AZENTA INC (AZTA). This can be considered as Fairly Valued.
Can you provide the profitability details for AZENTA INC?
AZENTA INC (AZTA) has a profitability rating of 3 / 10.
How financially healthy is AZENTA INC?
The financial health rating of AZENTA INC (AZTA) is 8 / 10.
What is the expected EPS growth for AZENTA INC (AZTA) stock?
The Earnings per Share (EPS) of AZENTA INC (AZTA) is expected to grow by 50.47% in the next year.